Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy

Rose A Schmidt^{1

2}

Affiliations

¹ Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
² Centre for Addiction and Mental Health (CAMH), Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Toronto, Canada.

Comment

Rose A Schmidt. Addiction. 2022 Jun.

. 2022 Jun;117(6):1818-1819.

doi: 10.1111/add.15830. Epub 2022 Feb 14.

Rose A Schmidt^{1

2}

¹ Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
² Centre for Addiction and Mental Health (CAMH), Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Toronto, Canada.

No abstract available

Keywords: Medication for opioid use disorder; comment; epidemiology; postpartum; pregnancy; substance use disorder.

Comment on

Outcomes associated with the use of medications for opioid use disorder during pregnancy.
Krans EE, Kim JY, Chen Q, Rothenberger SD, James AE 3rd, Kelley D, Jarlenski MP. Krans EE, et al. Addiction. 2021 Dec;116(12):3504-3514. doi: 10.1111/add.15582. Epub 2021 Jun 9. Addiction. 2021. PMID: 34033170 Free PMC article.